Deliver Your News to the World

Powerful Analytical Chemistry Software Solutions for CROs Through ACD/Labs Subscription Service


WEBWIRE

Toronto, Canada—Advanced Chemistry Development, Inc., (ACD/Labs) now offers subscription-access to their analytical chemistry software tools. These flexible licenses are offered with Contract Research Organizations (CROs) in mind, allowing subscribers access to the same powerful analytical software tools larger pharmaceutical firms possess without the major investment.

ACD/Labs has been supplying pharmaceutical, governmental, and industrial chemical organizations with advanced tools for interpretation, structure verification, and chromatographic method development for 16 years. Many CROs are faced with analytical chemistry data only on an intermittent basis—whereupon they are limited to standard vendor software and must contend with time-consuming and error prone manual interpretation. An ACD/Labs subscription will allow CROs and other smaller research organizations to call upon the most recent version of ACD/Labs software on a project-by-project basis.

Subscribers will have access to expert tools and comprehensive databases, and easy-to-produce customizable reports. Traceable results ensure transparency and accountability when submitting to clients or regulatory bodies for drug submissions.

For more information, and to download a case building whitepaper, visit www.acdlabs.com/crosubscriptions

About ACD/Labs: Founded in 1994, Advanced Chemistry Development, Inc., (ACD/Labs) has since supplied hundreds of industrial companies and academic organizations worldwide with software to speed research. Our solutions include fast and accurate prediction of molecular physical properties, property-based structure design, metabolite identification, analytical data processing and interpretation, chemical nomenclature, and chemical databasing. ACD/Labs is committed to ongoing development and improvement of its products, constantly improving the accuracy and usability of existing functionality, while also delivering exciting and innovative new capabilities aimed at solving customers’ challenges



WebWireID132671




 
 Drug Discovery
 Contract Reseach
 Pharma Outsourcing
 CRO


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.